AdaptHealth Corp. (NASDAQ:AHCO) Given Consensus Recommendation of “Moderate Buy” by Analysts

AdaptHealth Corp. (NASDAQ:AHCO) has received an average rating of “Moderate Buy” from the eight analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $14.2857.

Several research analysts recently issued reports on AHCO shares. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Robert W. Baird set a $18.00 price objective on shares of AdaptHealth in a report on Wednesday, May 6th. UBS Group decreased their target price on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $11.00 target price on shares of AdaptHealth in a report on Monday, April 20th.

Insider Transactions at AdaptHealth

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $10.06, for a total value of $113,426.50. Following the completion of the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. The trade was a 7.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by insiders.

Institutional Trading of AdaptHealth

A number of institutional investors have recently made changes to their positions in AHCO. Deerfield Management Company L.P. lifted its stake in shares of AdaptHealth by 15.9% in the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after purchasing an additional 1,572,835 shares during the period. Dimensional Fund Advisors LP raised its position in AdaptHealth by 15.6% in the third quarter. Dimensional Fund Advisors LP now owns 5,982,070 shares of the company’s stock worth $53,537,000 after acquiring an additional 809,459 shares during the period. Reinhart Partners LLC. raised its position in AdaptHealth by 10.6% in the fourth quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock worth $80,684,000 after acquiring an additional 773,727 shares during the period. Kennedy Capital Management LLC boosted its stake in shares of AdaptHealth by 48.8% during the 3rd quarter. Kennedy Capital Management LLC now owns 2,090,138 shares of the company’s stock worth $18,707,000 after acquiring an additional 685,554 shares during the last quarter. Finally, Iron Triangle Partners LP grew its position in shares of AdaptHealth by 35.6% during the 4th quarter. Iron Triangle Partners LP now owns 2,609,003 shares of the company’s stock valued at $25,986,000 after acquiring an additional 684,871 shares during the period. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Price Performance

Shares of NASDAQ AHCO opened at $10.76 on Tuesday. AdaptHealth has a 1 year low of $8.51 and a 1 year high of $13.43. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71. The company’s 50-day moving average is $10.66 and its 200 day moving average is $10.61. The stock has a market capitalization of $1.46 billion, a P/E ratio of -17.35, a P/E/G ratio of 0.55 and a beta of 1.45.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.